Profound Medical (NASDAQ:PROF – Get Free Report) and Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability.
Earnings & Valuation
This table compares Profound Medical and Guardian Pharmacy Services”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Profound Medical | $11.84 million | 15.03 | -$27.82 million | ($1.46) | -4.04 |
| Guardian Pharmacy Services | $1.23 billion | 1.51 | -$87.29 million | ($1.52) | -19.26 |
Insider & Institutional Ownership
47.9% of Profound Medical shares are owned by institutional investors. 1.5% of Profound Medical shares are owned by insiders. Comparatively, 63.7% of Guardian Pharmacy Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Analyst Ratings
This is a summary of recent ratings and recommmendations for Profound Medical and Guardian Pharmacy Services, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Profound Medical | 1 | 0 | 1 | 0 | 2.00 |
| Guardian Pharmacy Services | 1 | 0 | 3 | 0 | 2.50 |
Profound Medical currently has a consensus price target of $11.00, indicating a potential upside of 86.60%. Guardian Pharmacy Services has a consensus price target of $29.33, indicating a potential upside of 0.22%. Given Profound Medical’s higher possible upside, equities research analysts clearly believe Profound Medical is more favorable than Guardian Pharmacy Services.
Profitability
This table compares Profound Medical and Guardian Pharmacy Services’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Profound Medical | -343.97% | -89.74% | -73.06% |
| Guardian Pharmacy Services | -6.90% | -52.41% | -24.17% |
Risk & Volatility
Profound Medical has a beta of 0.66, meaning that its stock price is 34% less volatile than the S&P 500. Comparatively, Guardian Pharmacy Services has a beta of 0.96, meaning that its stock price is 4% less volatile than the S&P 500.
Summary
Guardian Pharmacy Services beats Profound Medical on 8 of the 14 factors compared between the two stocks.
About Profound Medical
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.
Receive News & Ratings for Profound Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Profound Medical and related companies with MarketBeat.com's FREE daily email newsletter.
